The University of Iowa
The University of Iowa News Services Home News Releases UI in the News Subscribe to UI News Contact Us
 
CONTACT: DAVE PEDERSEN
2130 Medical Laboratories
Iowa City IA 52242
(319) 335-8032; fax (319) 335-8034
e-mail: david-pedersen@uiowa.edu

Release: April 2, 1999

EDITOR'S NOTE: This release was originally sent out Oct. 15, 1998.

Additional volunteers sought for study with LDL-cholesterol lowering drug

IOWA CITY, Iowa -- The University of Iowa is one of 250 medical centers participating in an international study to determine if lowering LDL-cholesterol (bad cholesterol) beyond the current recommended level will decrease further heart problems in patients with known heart disease.

Participants in the study will be treated with the FDA-approved cholesterol-lowering drug Lipitor, also known as atorvastatin.

"We look forward to being a part of this important study," said Helmut Schrott, M.D, UI lead investigator and associate professor of preventive medicine and environmental health. "We are studying whether lowering LDL-cholesterol beyond current standards will achieve greater benefits."

Adults between the ages of 35 and 75 who have experienced a heart attack, chest pain or heart-related surgery in the past five years, may be eligible to participate in this five-year study.

Qualified people will receive medical monitoring including: annual physical with EKG, blood and lab evaluations and nutrition counseling, as well as medication to lower blood cholesterol.

If you are eligible and are interested in participating in the study, call the UI Lipid Research Clinic, (319) 335-6677 or 1-800-887-6917.